Objectives
The Antibodies/Peptides Unit provides solutions for all processes, from in silico design to laboratory-scale production and validation of antibodies and peptides used in the diagnostic and therapeutic fields.
Areas of impact and applications in the field
Monoclonal antibodies are one of the leading tools in the medical world, from diagnosis to treatment. The success of immunotherapy, especially in the field of cancer in the last 15 years, has made the field of monoclonal antibodies much more attractive. Similarly, developing and applying peptides with similar innovative approaches has brought great dynamism to the sector in recent years. The unit offers comprehensive solutions covering every process step, from cutting-edge in silico design to precise laboratory-scale production and validating antibodies and peptides.
AnkaTheraHub’s expertise is tailored to meet the international standards of the diagnostic and therapeutic fields to provide top-tier quality and effectiveness.
Services
- Peptide Synthesis
- Antibody Purification
- Peptide Characterization
- Therapeutic Antibody Production
- Peptide-Based Drug Discovery
- Oligonükleotit Sentezi
- 1 umole RNA Oligo 5-60 bases
- 1 umole DNA Oligo 5-100 bases
- 250 nmole RNA Oligo 5-60 bases
- 100 nmole RNA Oligo 10-60 bases
- 250 nmole DNA Oligo 5-100 bases
- 100 nmole DNA Oligo 10-90 bases
- 25 nmole DNA Oligo 15-60 bases
- 2 umole DNA Oligo 5-100 bases
- 5 umole DNA Oligo 5-100 bases
- 10 umole DNA Oligo 5-100 bases
- 100 nmole Duplex Oligo 10-90 bases
- 250 nmole Duplex Oligo 5-100 bases
- 1 umole Duplex Oligo 5-100 bases
